The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCOLADE INC | COM | 00437E102 | 20,785,026 | 5,398,708 | SH | SOLE | 5,398,708 | 0 | 0 | |||
| BIOAGE LABS INC | COM | 09077V100 | 62,690,680 | 3,013,975 | SH | SOLE | 3,013,975 | 0 | 0 | |||
| BLOCK INC | CL A | 852234103 | 68,250,870 | 1,016,697 | SH | SOLE | 1,016,697 | 0 | 0 | |||
| CYNGN INC | COM NEW | 23257B206 | 224,002 | 57,584 | SH | SOLE | 57,584 | 0 | 0 | |||
| DOORDASH INC | CL A | 25809K105 | 39,430,177 | 1,597,010 | SH | SOLE | 1,597,010 | 0 | 0 | |||
| ERASCA INC | COM | 29479A108 | 7,814,625 | 2,862,500 | SH | SOLE | 2,862,500 | 0 | 0 | |||
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | 37611X209 | 884,829 | 108,568 | SH | SOLE | 108,568 | 0 | 0 | |||
| MAPLEBEAR INC | COM | 565394103 | 114,155,843 | 2,802,058 | SH | SOLE | 2,802,058 | 0 | 0 | |||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 50,313,663 | 17,653,917 | SH | SOLE | 17,653,917 | 0 | 0 | |||
| OPENDOOR TECHNOLOGIES INC | COM | 683712103 | 12,401,642 | 6,200,821 | SH | SOLE | 6,200,821 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 124,645,518 | 2,748,523 | SH | SOLE | 2,748,523 | 0 | 0 | |||
| ROBINHOOD MKTS INC | COM CL A | 770700102 | 443,922,821 | 18,954,860 | SH | SOLE | 18,954,860 | 0 | 0 | |||
| SAMSARA INC | COM CL A | 79589L106 | 192,270,774 | 3,995,652 | SH | SOLE | 3,995,652 | 0 | 0 | |||